Summary The role of the pancreaticotrophic hormone cholecystokinin (CCK) in modifying the pancreatic response to carcinogen has been examined in the hamster-nitrosamine pancreatic cancer model. Exogenous CCK, 30 IDU kg-1, stimulated a maximal pancreatic secretory response when given intravenously and caused hypertrophy and hyperplasia of the pancreas when given subcutaneously over a period of 6 weeks (pancreatic wet weight, mg per lOOg body weight, controls 295.6+61; CCK treated 466.4+77, P<0.001). When the same dose of CCK was given to animals receiving N-nitrosobis (2-oxopropyl)amine (BOP; 5mgkg-1 weekly) there was a reduction in latency period and increase in induction rate of tumour development (CCK+BOP vs. BOP alone, 12 animals with tumours vs. 2 at 15 weeks; P<0.02). These effects are consistent with CCK acting as a co-carcinogen or promoter of pancreatic carcinogenesis in this model.
Although the aetiology of carcinoma of the pancreas is unknown, epidemiological studies have identified a number of associations which support the concept that pancreatic cancer is the result of chemical carcinogenesis (Wynder, 1975) . Potential carcinogens responsible for tumour development could be present in tobacco smoke (Hoffmann et al., 1974 (Hoffmann et al., , 1975 , food (Wynder, 1975) or particular occupational environments (Mancuso & El-Altar, 1967; Li et al., 1969) .
It has also been suggested that co-carcinogens or promoters (either exogenous or endogenous) may have an important role to play in enhancing the carcinogenic process. Of particular interest is the possibility that cholecystokinin, released from the duodenal mucosa as a result of the ingestion of a fat-protein rich diet, may by its pancreaticotrophic action increase pancreatic susceptibility to carcinogens. It is well recognised that increased cell metabolic activity and cell turnover increases tissue susceptibility to carcinogens (Rous & Kidd, 1941; Ryser, 1971) . This paper reports a series of experiments to determine the potential of cholecystokinin (CCK) to enhance pancreatic carcinogenesis in the hamster-nitrosamine model developed by Pour et al. (1977) .
Materials and methods
The animals used in all studies were 10 weeks old male Syrian hamsters kept under standardised Correspondence: A.G. Howatson *Present address: University Department of Pathology, Royal Infirmary, Castle Street, Glasgow.
Received 22 May 1984; and in revised form, 26 September 1984. conditions in groups of four and fed Oxoid 41B diet and water ad libitum.
Effect of CCK on pancreatic exocrine secretion The effect of step-wise increasing doses of exogenous cholecystokinin (20% natural CCK, GIH Research Unit, Karolinska Institute) was studied in twelve hamsters. The mean body weight of the animals was 84.3 + 8.5 g.
After a 24 h fast with free access to water the animals were anaesthetized with intraperitoneal "Sagatal" (May & Baker Ltd.) . Tracheostomy was performed and an intravenous cannula was inserted into the left jugular vein. A saline infusion (0.9%) at a rate of 0.375mlh-1 was commenced using a syringe infusion pump (B. Braun Melsugen AG). A laparotomy was performed through a midline incision, the common bile duct ligated in continuity just distal to the entry of the cystic duct, and the pylorus ligated. The common bile duct was cannulated in the wall of the duodenum to permit collection of pancreatic juice (Portex Ltd., 2FG, Outer diameter 0.63 mm). The cannula was secured by a suture and led out through the flank. The body temperature was maintained at 34°C with a heating pad.
An equilibration period of 1 h was allowed before commencement of the test. Pancreatic juice was collected in pre-weighed tubes placed below the hamster. A basal output was collected for 1 h and thereafter step-wise increasing doses of CCK in saline were infused. Collections at each dose level were made for 1 h, and 20 min was allowed for equilibration between doses. The volume output was measured by weighing. At The dose of CCK used in these studies was selected from the above dose response studies as that producing a maximal response in terms of pancreatic juice output when given intravenously.
In the first experiment two groups of 10 animals (mean body weight CCK group 95.6 ± 6.3 g; control group 88.4 + 7.2 g) received either CCK 30 IDU kg-1 twice daily by s.c. injection for 15 days in hydrolysed gelatin carrier or gelatin carrier alone. The CCK was made up in 10% hydrolysed gelatin in saline in order to prolong absorption (Petersen et al., 1978) .
In the second experiment, two groups of 10 animals (mean body weight CCK group 77.6 +4.6 g; control group 83.1 + 7 g) received either CCK 30 IDU kg 1 twice daily for 3 days per week for 6 weeks in hydrolysed gelatin carrier, by s.c. injection, or gelatin carrier alone.
At the end of each experiment the animals were killed, the pancreas removed, trimmed of fat and connective tissue and weighed. Tissue from two sites in both the gastric and splenic lobes of the pancreas was fixed in formalin and examined histologically after staining with haematoxylin and eosin and was assessed using the same criteria as in the carcinogen experiment. In addition to recording pancreatic wet weight (PWW: mg pancreas per 100 g body weight), the pancreatic content of DNA (Mug DNA per 100mg PWW) was also determined.
The DNA was extracted from the homogenised pancreas by the method of Schmidt-Thanhauser as modified by Munro & Fleck (1966) and measured by the modified Burton method (Burton, 1956; Giles & Myers, 1965 Twenty animals from each treatment group were scheduled to be killed at 5, 7.5, 10, 12.5 and 15 weeks. A full post-mortem examination was performed and all major organs were examined macroscopically for the presence of neoplastic lesions. The pancreas was fixed en bloc in 10% formalin and the whole organ was blocked, there being an average of 11 blocks from each pancreas. Three sections were taken from each block for examination by light microscopy after staining with haematoxylin and eosin. Macroscopic tumour nodules, where present, were excised from the main pancreatic specimen at the time of post-mortem and separately sectioned for histological confirmation.
Each pancreas was assessed for the presence of the following histological appearances affecting ducts or of ductular morphology; duct dysplasia, duct carcinoma-in-situ, ductular proliferation (tubular complexes) and acinar-ductular transformation affecting an entire lobule, and pancreatic adenocarcinoma. Malignant tumours that were intralobular and those that were frankly invasive, i.e. extending outside the boundaries of a pancreatic lobule, have been classified together under the single heading of adenocarcinoma. If any of these ductal/ductular lesions were present in a histological section it was recorded as present for that pancreas. No formal attempt was made to quantify the extent or frequency of the lesions in the pancreas. For the purposes of the histological assessment, duct dysplasia and carcinoma-in-situ have been reported separately. These lesions represent atypical duct hyperplasia of varying degrees of severity. The presence of mitoses was a pre-requisite for an atypical hyperplastic lesion with nuclear pleomorphism and loss of epithelial maturation to be regarded as carcinoma-in-situ ( Figure 1 ). The development of ductules, or tubular complexes, both as a result of ductular cell hyperplasia and acinar-ductular transformation was regarded as a significant premalignant lesion if virtually all of a lobule was involved in the process ( Figure 2 ). Intralobular carcinoma was defined as a focus of carcinoma confined within the boundaries of a pancreatic lobule. When the lobular boundary was transgressed, the lesion was classified as frankly invasive carcinoma (Figure 3 ). The progress and development of these ductal/ductular and acinar transformation lesions is outlined in Figure 4 .
All sections were examined by a single observer (AGH) and a proportion of slides (' 20%), randomly selected by an individual not involved in the series of experiments, were examined by a trained pathologist who was not aware of the nature and duration of the treatment given to any particular animal. weeks, but by 7.5 weeks this was present in 15% of the control group and 50% of the CCK treated group.
The results of the histological assessments of the groups at 10, 12.5 and 15 weeks are shown in Tables I-III. At 10 weeks there was a significant excess of duct carcinoma-in-situ and panlobular ductular proliferation in the CCK treated group as compared to the control group. There were no adenocarcinomas in either group at 10 weeks. By 12.5 weeks more animals in the control (carcinogen alone) group developed ductal lesions. A significant difference between the two groups was seen with respect to panlobular ductular proliferation and adenocarcinomas which were more frequent in the CCK treated group. At 15 weeks a significant excess of adenocarcinomas, developing from panlobular ductular proliferation was seen once again in the CCK treated group. Premalignant and (Pour et al., 1977) . The origin of these lesions is the source of some controversy but it appears from the present study that the neoplastic cells arise from both ductal/ductular cells as suggested by Pour (1978) and by the transformation of acinar cells to cells of ductular morphology as reported by Scarpelli & Rao (1978) . This model is widely considered to approximate most closely to the morphology and biology of human pancreatic cancer. The tumours are of ductular morphology, the predominant pattern of pancreatic cancer in man (Cubilla & Fitzgerald, 1980) , and will invade locally, obstruct the common bile duct causing jaundice, and metastasize to lymph nodes, liver and other sites (Pour et al., 1977) . proliferation between the BOP + CCK and BOP alone groups at 15 weeks probably reflects the fact that in the majority of animals, in the CCK group, the lobular lesions had progressed to adenocarcinoma. In the 12 of 17 animals with adenocarcinoma the lesions were present in several lobules in the majority. This implies that the interval between sampling was such that the premalignant phase was missed in most cases because of the rapid progress of the neoplastic process in this group as compared to the controls.
In the case of pancreatic lobular carcinoma and invasive carcinoma the lesions appeared earlier in the CCK treated group than in the carcinogenalone controls. The reduction in latency period and increased induction rate of tumour development is consistent with cholecystokinin serving as a cocarcinogen or promoter.
CCK is trophic to both acinar and ductular cells but it is generally accepted that its principal function is to serve as a hormone trophic to acinar cells.. The capacity of CCK to enhance carcinogenesis as described above may be mediated simply through the generation of increased numbers of susceptible cells and intracellular targets for carcinogen as a result of increased cell metabolism and proliferation. However, a more interesting and appealing concept is that CCK might influence the metabolism of carcinogen.
N-nitrosobis (2-oxopropyl)amine is an indirect carcinogen, as are all the nitrosamines, and must be metabolised to produce carcinogenic forms. It is now accepted that nitrosamines are metabolised by mixed function oxidase (MFO) enzyme systems of a number of tissues. The organ specificity of a given carcinogen may well depend on the capacity of a given tissue to metabolise the carcinogen. This metabolism, in situ, of the indirect carcinogen or a more proximate form transported to the target organ after metabolism elsewhere, liver for example, may be critical because of the very short lived nature of the electrophilic radicals which are generated in the final steps of the carcinogenic processes (Miller, 1970) . Early studies of nitrosamine metabolism focussed on hepatic MFO enzymes but more recently it has been clearly shown that the pancreas, among other tissues, also contains MFO enzymes which can metabolise carcinogenic nitrosamines and generate mutagenic metabolites as demonstrated by the Ames assay (Scarpelli et al., 1980) . Studies with the tritium labelled carcinogenic nitrosamine N-nitroso-2,6,di-methylmorpholine, have shown that both acinar and ductal cells can metabolise nitrosamines. The acinar cell population appear to be the major site of metabolic activation (Reznik-Schuller et al., 1980) . Scarpelli et al. (1980) have shown in vitro, that pancreatic MFO enzymes are inducible and that the induction of these enzymes is associated with an increase in the conversion of carcinogens to mutagens. In vitro studies have shown that the alkylation of guanine at the 0-6 position, by electrophilic radicals derived from nitrosamine, causes mutagenesis (Gerchman & Ludlum, 1973; Margison et al., 1976) . The trophic effect of CCK on the pancreas as demonstrated in this paper might include stimulation of those MFO enzymes capable of nitrosamine metabolism. An increase in metabolism of the carcinogen with greater production of electrophilic radicals could enhance the mutagenic effect by increasing alkylation of DNA.
The present series of experiments may have important implications for our understanding of the pathogenesis of pancreatic cancer in hamsters and other species including man. We have demonstrated that exposure of the pancreas to a hormone, normally released from the duodenum by the ingestion of fat and protein, that acts as a stimulant of pancreatic exocrine activity, potentiates the action of carcinogen and/or increases pancreatic susceptibility to carcinogen. The consumption of a fat-protein rich diet is associated with an increased incidence of pancreatic cancer (Wynder, 1975; Armstrong & Doll, 1975) . Our studies suggest a mechanism by which diet may affect pancreatic carcinogenesis.
